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Condensation of N10(acetohydrazido) phenothiazine/ben-
zotriazole 5, 6 with various carbonyls give arylidene acetohy-
drazido phenothiazines/benzotriazoles 7, . 8 which on
cycloaddition with mercapto acetic acid yield the corresponding
4-thiazolidinones 9a-e and lOa-e. Treatment of these 4-thiazolid-
inones with various carbonyl compounds afford 5-arylidene-
2-aryl-3-(phenothiazino/benzotriazolo acetamidyl)-1,3-thia-
zolidine-t-ones 11a-1 and 12a-1 respectively.
Phenothiazine and benzotriazole derivatives pos-
sess potent biological activities'< including an-
thelmintic and antiinflammatory activities.
4-Thiazolidinones are well known for versatile phar-
macological activitiest' such as hypnotic, anaes-
thetic, antifungal, analgesic, antiviral, antithyroid,
anticonvulsant, CNS stimulant, etc.
The present paper reports the synthesis of 4-thia-
zolidinones by appropriate methods. All the com-
pounds have been screened for their
antiinflammatory activity against the carrageenan
induced rat paw oedema in albino rats, anticonvul-
sant activity against pentylenetetrazole induced con-
vulsions in mice, analgesic activity by the Eddy and
Leimbach method using Technoheated plate analge-
sic apparatus and antimicrobial activity by the agar
plate diffusion technique.
Phenothiazine/benzotriazole on N-esterification
with ethyl chloroacetate in acetone/chloroform gave
ethyl ethanoate/phenothiazine/benzotriazole 3, 4
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ethanol/methanol yielded acetohydrazido phe-
nothiazine/benzotriazole 5, 6. Compounds 5, 6 on
condensation with various carbonyls afforded
arylidene acetohydrazido phenothiazine/benzotria-
zole 7, 8 which on cyclocondensation with thiogly-
colic Acid in presence of anhyd. ZnCh furnished
2-aryl-3- (phenothiazino/benzotriazolo acetamidyl)-
I ,3-thiazolidene-4-ones 9, 10. Compounds 9, 10 on
reaction with various carbonyls using sodium ethox-
ide in dioxane/benzene yielded 5-arylidene-2-aryl-3-
(phenothiazino/benzotriazolo acetamidyl)-1,3-thia-
zolidine-4-ones 11, 12 (Scheme I).
The structures of these compounds were estab-
lished on the basis of their elemental analysis, JR,
PMR and mass spectra (Table I).
Biological activities
Antiinflammatory activity
Carrageenan induced rat paw oedema method was
employed for evaluating the antiinflammatory activ-
ity of 11 a-I and 12 a-l at a dose of 4 mglkg b.w. in
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Table I-Characterization data of compounds 7-12




7b H CH=CH.C6Hs 57 138 CnHJ9N30S 71.6 4.8 10.8
(71.6) (4.9) (10.9)
c H p-CI.C6H4 61 93 C2JHJ6N30SCI 64.0 3.9 10.5
(64.0) (4.0) ( 106)
d H o-CI.C6H4 63 91 C2JHJ6N30SCI 64.0 4.0 10.5
(64.0) (4.0) (10.6)
e C6Hs C6Hs 66 178 C27H21N30S 74.4 4.7 9.6
(74.4) (4.8) (9.6)
8b H CH=CHC6Hs 54 82 CJ7HJsNsO 66.7 4.9 22.9
(66.8) (4.9) (22.9)
c H P-CI.C6Hs 55 79 CJSH12NsOCI 57.3 3.7 22.3
(57.4) (3.8) (22.3)
d H o-CI.C6H4 55 77 CJSHJ2NsOCI 57.3 3.7 22.3
(57.4) (3.8) (22.3)
e C6Hs C6Hs 56 67 C21HJ7NsO 70.9 4.7 19.6
(70.9) (4.7) (19.7)
9b H CH=CH.C6Hs 64 142 C2sH2JN302S2 65.2 4.3 9.1
(65.3) (4.5) (9.1 )
c H p-CI.C6H4 47 89 CnHJ8N302S2CI 59.0 3.7 8.8
(59.0) (3.8) (8.9)
d H o-CI.C6H4 50 87 CnHJ8N302S2CI 59.0 3.7 8.9
(59.0) (3.8) (8.9)
e C6Hs C6Hs 47 173 C29HnN302S2 68.1 4.4 8.1
(68.3) (4.5) (8.2)
lOb H CH=CH.C6Hs 71 90 CJ9H17Ns02S 60.0 4.2 18.4
(60.1) (4.4) ( 18.4)
c H p-CI.C6H4 65 74 C17HJ4Ns02SCI 52.5 3.5 18.0
(52.6) (3.6) (18.0)
d H o-CI.C6H4 69 72 CJ7HJ4NS02SCI 52.6 3.5 18.0
(52.6) (3.6) ( 18.0)
e C6Hs C6Hs 60 67 CnHJ9Ns02S 64.3 4.4 16.3
(64.3) (4.4) (16.3)
lib H C4H30 H p-CI.C6H4 61 83 C28H20N303S2CI 61.5 3.6 7.6
(61.5) (3.6) (7.6)
c H C4H30 H p-N(CH3)2.C6H4 58 103 C30H26N403S2 64.8 4.6 10.0
(64.9) (4.6) (10.1 )
d H C4H30 C6H5 C6Hs 51 121 C34H25N302S2 69.4 4.2 7.1
(69.5) (4.2) (71)
e H CH=CH.C6Hs H p-CI.C6H4 48 87 C32H24N302S2CI 66.0 4.1 7.1
(66.0) (4.1 ) (7.1 )
f H CH=CH.C6H5 H p-N(CH3)2C6H4 51 154 C34H30N402S2 69.0 5.0 9.2
(69.1) (5.0) (9.4)
g H CH=CH.C6H5 H C6H5 57 171 C38H29N302S2 73.0 4.5 6.7
(73.1) (4.6) (6.7)
h H p-CI.C6H4 H o-CI.C6H4 51 74 C30H2JN302S2Ch 61.0 3.5 7.0
(61.0) (3.5) (7.1)
H p-CI.C6H4 H p-N(CH3)2.C6H4 56 III C32H27N402S2CI 64.1 4.4 9.1
(64.1) (4.5) (9.3)
Contd ...
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Table I-Characterization data of compounds 7-12 (Contd ..)




H p-CI.C6H4 C6H5 C6H5 55 116 C36H26N302S2CI 68.3 4.1 6.4
(68.4) (4.1) (6.6)
k H o-CI.C6H4 C6H5 C6H5 53 118 C36H26N302S2CI 68.3 4.1 6.4
(68.4) (4.1) (6.6)
C6H5 C6H5 H p-N(CH3)2C6H4 50 161 C3sH32N402S2 71.1 5.0 8.7
(71.2) (5.0) (8.7)
12b H C4H30 H p-CI.C6H4 55 32 C22HI6N503SCI 56.6 3.3 15.0
(56.7) (3.4) (15.0)
c H C4H30 H p-N(CH3)2C6H4 50 53 C24H22N603S 60.7 4.6 17.7
(60.7) (4.6) (17.7)
d H C4H30 C6H5 C6H5 49 66 C2sH2IN503S 66.2 4.0 13.7
(66.2) (4.1) ( 13.8)
e H -CH=CH.C6H5 H p-CI.C6H4 53 44 C26H20N502SCI 62.1 3.9 13.9
(62.2) (3.9) (13.9)
f H -CH=CH.C6H5 H p-N(CH3)2C6H4 58 70 C2sH26N602S 65.8 5.0 16.2
(65.8) (5.0) (16.4)
g H -CH=CH.C6H5 C6H5 C6H5 55 85 C32H25N502S 70.8 4.5 12.8
(70.9) (4.6) (12.8)
h H p-CI.C6H4 H -CI.C6H4 48 29 C24HI7N502SCb 56.4 3.3 13.6
(56.4) {3.3) (13.7)
H p-CI.C6H4 H p-N(CH3)2C6H4 51 64 C26H23N602SCI 60.1 4.4 16.1
(60.1) (4.4) (16.2)
H p-CI.C6H4 C6H5 C6H5 55 68 C30H22N502SCI 65.2 3.9 12.4
(65.2) (3.9) (12.6)
k H o-CI.C6H4 C6H5 C6H5 56 67 C30H22N502SCI 65.2 3.9 12.4
(65.2) (3.9) ( 12.6)
C6H5 C6H5 H p-N(CH3)2C6H4 63 74 C32H2SN602S 68.5 5.0 14.9
(68.5) (5.0) ( 15.0)
albino rats (weighing 80-115 g). the rat paw oedema
was produced by the method of Winter et al.6 The
percentage inhibition of inflammation was calculated
by applying Newbould formula? In this test the most
active compounds were lle, f, g, 1 (58%, 72%, 52%
and 75%) and 12a,e,d,f,g,1 (58%, 66%, 50%, 83%, .
80% and 75%) inhibition respectively and their ac-
tivity was compared with phenylbutazone (94% in-
hibition) at a dose of 4 mglkg b.w.
Anticonvulsant activity
The compounds lla-J and 12a-J were screened for
their anticonvulsant activity against the pentylene
tetrazole induced convulsion in albino rats of either
sex (weighing 80-115 g) by the method given in
literature8,9. ~he compounds were suspended in 5%
aq. gum acacia to give a concentration of25% (w/v).
The test compounds were injected i.p. at a dose of 50
mglkg b.w. 4 hr after the administration of com-
pounds. The rats were injected with pentylenetetra-
zole (50 mg/kg). Compounds Ilf,g,J and 12f,g
provided 80, 70, 60, 50 and 40% protection respec-
tively against the pentylenetetrazole induced convul-
sions in rats compared to 100% activity of
phenobarbitone (a reference drug) at 50 mg/kg b.w.).
Analgesic activity
The synthesised compounds lla-J and 12a-J were
tested for their analgesic activity in albino rats
(weighing 80-115 g) by Eddy and Leimbach
methodlO at an oral dose 25 mg/kg b.w. Acetyl
salicylic acid was employed as a standard drug. The
synthesised compounds lta,b,c,i and 12b,c,g were
found to show 158.41, 183.29,253.16,281.81, 147.5,
173.49 and 222.19% analgesic activity respectively.
Antimicrobial activity
The compounds 9-12 were screened for their an-
tibacterial activity against Bacillus subtilis, Salmo-
nella typhimurium and Escherichia coli and
antifungal activity against Candida albicans, Fusar-
ium heterosporium and Aspergillus niger by filter
paper disctechnique'J'V ar two concentrations (25
and 50 ug/rnl). Standard antibactenal streptomycin
and antifungal griseofulvin were also screened under
similar conditions for comparison. The compounds
1lf,1 and 12c,f,g,1 had good antibacterial activity
while compounds ltc,f,1 and 12a,f,1 were found to
have pronounced antifungal activity.
Experimental Section
Melting points were taken in an open capillary
tube and are uncorrected. IR spectra (KBr) were
recorded on an Acculab-IO spectrophotometer
(umax in em-I)and PMR spectra in CDCI3on 90 MHz on
Varian CFT-20 instrument using TMS as an internal
standard (chemical shifts in 8, ppm).
Ethyl ethanoate phenothiazine 3lbenzotriazole 4.
Ethyl chloroacetate (0.05mole) was added to a solu-
tion of phenothiazinelbenzotriazole (0.05 mole) and
anhyd. K2C03 (3 g) in ethanol and the reaction mix-
ture was refluxed for 15 hr. Solvent was removed in
vacuo and the residue was crystallised from chloro-
form to give 3, yield 82%, m.p. 203° (Found: C,67.3;
H,5.2; N,4.8. CI6HIS02NS requires C,67.4; H,5.3;
N,4.9%); IR: 3020, 1580,925, 755, 740, 680 and 650
(phenothiazine nucleus), 1720(>C=O ester); PMR:
1.20(t,3H,J= 7Hz, -COOCH2CH3), 4.10(q, 2H, J=
7Hz: COOCH2CH3), 3.60(s, 2H, N-CH2), 7.20-7.90
(m, 8H, Ar-H); MS: 285(M+). 4: Yield 83%, m.p. 40°
(Found: C,58.5;.H,5.3; N,20.4. CIOHII02H3 requires
C,58.5; H,5.4; N,20.5%); IR: 3020, 1620, 1485,865,
725 (benzotriazole nucleus), 1715(>C=O); PMR:
1.20 (t, 3H, J = 7Hz, COOCH2CH3), 3.60(s, 2H,
N-CH2), 4.10(q, 2H, J= 7Hz, COOCH2CH3), 7.30-
7.80(m, 4H, Ar-H); MS: 205(M+).
Acetohydrazido phenothiazine 5lbenzotriazole 6.
A mixture of3/4 (0.028 mol) and hydrazine hydrate
(100%; 0.028 mole) was Orefluxed on a steam bath
for S hr, cooled and filtered to get compounds 5/6. 5:
Yield 76%, m.p. 170° (Found: C,61.9; H, 4.6; N, 15.3.
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CI4H130N3S requires C,62.0; H,4.8; N,15.5%);
IR:3350-3200(- NHNH2), 1660(>C=O, amido);
PMR; 2.50(s, 2H, -NH2), 3.65 (s, 2H, N-CH2), 7.10-
7.80(m, 8H, Ar-H), 8.20 (s, IH, CONH); MS:
271(M+). 6:Yield 60%, m.p. 85° (Found: C,50.2;
H,4.7; N,36.S. CgH90Ns requires C,50.3; H,4.7;
N,36.6%); IR: 3350(NHNH2), 1660(>C=O, amido);
PMR: 2.50(s, 2H, NH2), 3.65 (s, 2H, N-CH2), 7.90
(s, IH, CONH), 7.40-7.70 (m, 4H, Ar-H); MS:
191(M+).
Arylidene acetohydrazido phenothiazine 7a!ben-
zotriazole 8a. A mixture of 5a16a (0.0036 mole),
furfuraldehyde (0.0036 mole) and 2-3 drops of gl.
acetic acid in ethanol (26 mL) was refluxed on a
steam bath for 5 hr. The solvent was removed under
reduced pressure to yield a product 7a18a respec-
tively, 7a: Yield 82%, m.p. 143° (Found: C,65.1;
H,4.2; N,12.0%. CI9HISN302S requires C,65.3;
H,4.2; N,12.0%); IR: 3300-3290(-NH- ),
1670(>C=O), I620(-CH=N-); PMR: 4.40(s, IH, -
N=CH-), 3.70(s, 2H, N-CH2), 8.00 (s, IH, -CONH-).
and 7.00-7.90 (m, II H, Ar-H); MS:349(M+). 8a:
Yield 58%, m.r.76° (Found: C,57.9; H,4.0; N,26.0%.
C13HIINs02 requires C,57.9; H,4.0; N,26.0%); IR:
3300-3280 (-NH-), I680(>C=O), I620(-CH=N-);
PMR: 4.50(s, IH, -N=CH-), 3.70 (s, 2H, N-CH2),
8.10 (s, IH, -CONH) and 7.30-7.90(m, 7H, Ar-H);
MS: 269(M+). Other compounds 7b-e and 8b- e were
prepared from 5 and 6 similarly using different car-
bonyl compounds. Characterization data are pre-
sented in Table I.
2 Aryl-3-[phenothiazino 9a/benzotriazolo lOa
acetamidyl]-l,3- thiazolidine-4-ones. To a stirred
solution of7a18a (0.0025 mole) in dioxane contain-
ing a pinch of anhyd. ZnCh, mercaptoacetic acid
(0.0025 mole) was added and the mixture was re-
fluxed on a steam bath for about 12 hr. Solvent was
distilled off at reduced pressure and recrystallized
from methanol/chloroform to yield compounds 9a
and lOa respectively. 9a: Yield 60%, m.p. 148°
(Found: C,59.4; H,4.0; N,9.8%. C21H17N303S2 re-
quires C,59.5; H,4.0; N,9.9%); IR: 3240 (-NH-),
1715(>C=O, cyclic), 1670(>C=O, amidyl); PMR:
3.20(s, IH, CHN-), 3.40(s, 2H, CH2-S-), 3.70 (s, 2H,
NCH2), 8.60 (s, IH, CONH) and 7.10-7.90 (m, IIH,
Ar-H); MS: 423(M+). lOa: Yield 65%, m.p.78°
(Found: C,52.4; H,3.7; N, 20.3%. ClsH13Ns03S re-
quires C,52.4; H,3.7; N,20.4%); IR: 3240-3220(-
NH-), I720(>C=O, cyclic), I 670(>C=O, amidyl);
PMR: 3.20(s, IH, -CHN-), 3.40(s, 2H, CH2S), 3.70
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(s, 2H, NCH2), 8.S0(s, lH, -CONH-) and 7.40-7.90
(rn, 7H, Ar-H); MS: 343(~). Other compounds 9b-e
and 10b-e were synthesised in the similar way using
7b-e and 8b-e respectively. Characterisation data are
presented in Table I.
5-arylidene-2-aryl-3-[phenothiazino 1ta/ben-
zotriazolo 12a acetamidyl]-1,3-thiazolidine-4-
ones. Equimolar solution of 9a/10a (0.0015 mole)
and cinnamaldehyde in dioxane in the presence of
C2HsONa was refluxed for 3 hr on a steam bath and
the solvent was removed under reduced pressure. The
products so obtained were recrystallised from etha-
nol to give 11a and 12a respectively. 11a: Yield ?2%,
m.p.76° (Found: C, 67.0; H, 4.1; N, 7.7%,
C)OH23N)O)S2requires C, 67.0; H, 4.2; N, 7.8%); IR:
3340(-NH-), 1715(>C=O, cyclic), 1650(>CO;
am idyl), 1630(>C=CHAr); PMR: 3.20 (s, 1H, -CHN-
), 3.60(s, 2H, -NCH2), 5.20 (s, IH, >C=CHAr), 8.70
(s, IH, -CONH), 7.10-8.00(m, 16H, Ar-H); MS:
537((~). ~2a: Yield 57%, m.p. 47°(Found: C,63.0;
H, 4.1; N,15.2%. C24H19NSO)S requires C,63.0;· H,
4.1; N, 15.3%); IR: 3330(-NH-), 1720(>C=Ocyclic),
1650(>C=O, am idyl), 1620(>C=CHAr); PMR:
3,30(s, IH, CHN), 3.60 (s, 2H, NHCH2), 5.20(s, IH,
>C=CHAr), 8.70 (s, IH, CONH), 7. 10-8.00(m, 12H,
Ar-H); MS: 457(~). Other compounds llb-I and
12b-1 were synthesised similarly from 9b-e and lOb-
e respectively and carbonyl compounds. Charac-
terization data are presented in Table I.
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